Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant Complement C4d antibody

The Rabbit Monoclonal anti-Complement C4d antibody is suitable to detect Complement C4d in samples from Human. It has been validated for ELISA, IHC and WB.
Catalog No. ABIN7863829
$640.46
Plus shipping costs $50.00
Shipping to: United States
Delivery in 2 to 5 Business Days

Quick Overview for Recombinant Complement C4d antibody (ABIN7863829)

Target

Complement C4d (C4d) (Complement Component C4d (C4d))

Antibody Type

Recombinant Antibody

Reactivity

  • 39
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 29
  • 12
Rabbit

Clonality

  • 33
  • 8
Monoclonal

Conjugate

  • 23
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
This Complement C4d antibody is un-conjugated

Application

  • 22
  • 21
  • 15
  • 14
  • 12
  • 10
  • 9
  • 7
  • 4
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
ELISA, Immunohistochemistry (IHC), Western Blotting (WB)

Clone

C4D-9213R
  • Purpose

    Recombinant Complement 4d (C4d) (Acute Humoral Rejection Marker) Antibody

    Specificity

    This MAb is specific to Complement 4d (C4d) and reacts with the secreted as well as cell-bound C4d.C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of Abs to specific target molecules. Following activation and degradation of the C4 Molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product Complement 4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival. Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant full-length human Complement 4d protein

    Isotype

    IgG, kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Target

    Complement C4d (C4d) (Complement Component C4d (C4d))

    Alternative Name

    Complement 4d

    Background

    Acidic Complement C4, Basic C4, C4-1, C4a Anaphylatoxin, C4A, C4A2, C4A3, C4A4, C4A6, C4b, C4B1, C4B12, C4d fragment, C4F, C4S, Complement C4 Gamma Chain, Complement Component 4A, Complement Component 4B

    Rejected Renal Transplant Tissue

    Molecular Weight

    192kDa (predicted)

    Gene ID

    720, 721

    UniProt

    P0C0L4, P0C0L5
You are here:
Blank Blank Blank Blank
Blank Blank Blank Blank
Chat with us!